Balance Sheet Themis Medicare Limited

Stocks

530199

INE083B01024

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:30:47 11/06/2026 pm IST			5-day change	1st Jan Change
100.20 ^INR	-2.72%		-8.07%	-0.45%

28/05	Themis Medicare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
28/05	Themis Medicare Limited Recommends Final Dividend for the Financial Year Ended 31 March, 2026	CI

3ee0d.JHS-o0TsNLnuEG4BAxRwUaYvNui--JMJUsmJ9TF5UXE.dg7t7x2IYcqKIgxRUkxDH952coP7wMFeDfH6twMVEBkRDfD3ArtC1qJ8Jw

Published financial data: THEMIS MEDICARE LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	230.67Cr	394.61Cr	354.32Cr	381.76Cr	405.51Cr
Total Revenues	230.67Cr	394.61Cr	354.32Cr	381.76Cr	405.51Cr
Cost of Goods Sold, Total	80Cr	150.88Cr	120.89Cr	138.87Cr	134.29Cr
Gross Profit	150.53Cr	243.73Cr	233.43Cr	242.89Cr	271.22Cr
Selling General & Admin Expenses, Total	44Cr	61Cr	78Cr	100Cr	114.54Cr
Depreciation & Amortization - (IS)	8.55Cr	9.48Cr	10Cr	12Cr	9.93Cr
Other Operating Expenses	57Cr	87Cr	88Cr	92Cr	107.64Cr
Other Operating Expenses, Total	109.59Cr	157.58Cr	176.47Cr	203.63Cr	232.1Cr
Operating Income	41Cr	86Cr	57Cr	39Cr	39Cr
Interest Expense, Total	-11Cr	-6.54Cr	-7.99Cr	-7.63Cr	-8.49Cr
Interest And Investment Income	2.34Cr	3.72Cr	4.75Cr	2.44Cr	1.55Cr
Net Interest Expenses	-8.63Cr	-2.82Cr	-3.24Cr	-5.18Cr	-6.94Cr
Income (Loss) On Equity Invest.	9.47Cr	11Cr	14Cr	19Cr	5.93Cr
Currency Exchange Gains (Loss)	58.13L	1.52Cr	3.23Cr	1.67Cr	1.5Cr
Other Non Operating Income (Expenses)	-1.05Cr	-93.91L	1.95Cr	-1.11Cr	7L
EBT, Excl. Unusual Items	41Cr	95Cr	73Cr	53Cr	40Cr
EBT, Incl. Unusual Items	41Cr	95Cr	73Cr	53Cr	40Cr
Income Tax Expense	5.63Cr	22Cr	16Cr	9.92Cr	9.84Cr
Earnings From Continuing Operations	36Cr	73Cr	57Cr	44Cr	30Cr
Net Income to Company	36Cr	73Cr	57Cr	44Cr	30Cr
Minority Interest	1T	1T	2T	3T	2T
Net Income - (IS)	36Cr	73Cr	57Cr	44Cr	30Cr
Net Income to Common Incl Extra Items	36Cr	73Cr	57Cr	44Cr	30Cr
Net Income to Common Excl. Extra Items	36Cr	73Cr	57Cr	44Cr	30Cr
Per Share Items
Net EPS - Basic	3.89	7.92	6.18	4.73	3.24
Basic EPS - Continuing Operations	3.89	7.92	6.18	4.73	3.24
Basic Weighted Average Shares Outstanding	9.19Cr	9.2Cr	9.2Cr	9.2Cr	9.2Cr
Net EPS - Diluted	3.88	7.91	6.17	4.72	3.24
Diluted EPS - Continuing Operations	3.88	7.91	6.17	4.72	3.24
Diluted Weighted Average Shares Outstanding	9.19Cr	9.22Cr	9.22Cr	9.22Cr	9.22Cr
Normalized Basic EPS	2.81	6.47	4.92	3.63	2.69
Normalized Diluted EPS	2.81	6.46	4.92	3.62	2.69
Dividend Per Share	0.43	0.5	0.5	0.5	0.5
Payout Ratio	4.5	5.43	8.08	10.57	15.43
Supplemental Items
EBITDA	49Cr	95Cr	67Cr	51Cr	49Cr
EBITA	41Cr	86Cr	57Cr	39Cr	39Cr
EBIT	41Cr	86Cr	57Cr	39Cr	39Cr
EBITDAR	50Cr	96Cr	68Cr	53Cr	52Cr
Total Revenues (As Reported)	234.29Cr	401.16Cr	365.83Cr	386.52Cr	410.18Cr
Effective Tax Rate - (Ratio)	13.62	23.49	21.53	18.56	24.81
Total Current Taxes	-	17Cr	15Cr	9.22Cr	8.3Cr
Total Deferred Taxes	5.63Cr	5.63Cr	61.41L	69.97L	1.54Cr
Normalized Net Income	26Cr	60Cr	45Cr	33Cr	25Cr
Non-Cash Pension Expense	-15.84L	-14.09L	-10L	-4L	5L
Supplemental Operating Expense Items
Advertising Expense	3.54Cr	8.06Cr	10Cr	15Cr	15Cr
Selling and Marketing Expenses	3.54Cr	8.06Cr	10Cr	15Cr	15Cr
Research And Development Expense From Footnotes	8.5Cr	10Cr	13Cr	13Cr	13Cr
Net Rental Expense, Total	83.38L	97.94L	1.81Cr	2.17Cr	3.45Cr
Imputed Operating Lease Interest Expense	75.74L	61.13L	1.34Cr	1.41Cr	2.62Cr
Imputed Operating Lease Depreciation	8L	36.81L	46.5L	76.25L	82.82L
Maintenance & Repair Expenses, Total	1.56Cr	2.74Cr	2.53Cr	2.16Cr	2.3Cr
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	19Cr	20Cr	13Cr	9.92Cr	6.56Cr
Short Term Investments	33T	33T	-	-	-
Total Cash And Short Term Investments	19Cr	20Cr	13Cr	9.92Cr	6.56Cr
Accounts Receivable, Total	78Cr	100.56Cr	145.02Cr	177.95Cr	177.1Cr
Other Receivables	76.71L	76.71L	16.61L	16.61L	-
Notes Receivable	-	-	-	-	-
Total Receivables	78Cr	101.33Cr	145.19Cr	178.11Cr	177.1Cr
Inventory	58Cr	61Cr	69Cr	71Cr	84Cr
Prepaid Expenses	4.03Cr	4.13Cr	5.46Cr	6.22Cr	5.76Cr
Restricted Cash	2.36Cr	2.47Cr	3.21Cr	6.12Cr	2.71Cr
Other Current Assets, Total	23Cr	25Cr	29Cr	22Cr	27Cr
Total Current Assets	185.47Cr	214.16Cr	264.53Cr	293.17Cr	303.87Cr
Gross Property Plant And Equipment	172.41Cr	192.62Cr	221.32Cr	241.57Cr	255.27Cr
Accumulated Depreciation	-38Cr	-47Cr	-57Cr	-71Cr	-81Cr
Net Property Plant And Equipment	134.37Cr	145.57Cr	164.03Cr	170.42Cr	174.54Cr
Long-term Investments	45Cr	58Cr	70Cr	90Cr	96Cr
Other Intangibles, Total	1.21Cr	98.88L	77.04L	55.2L	33.36L
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	4.86Cr	8.94Cr	14Cr	12Cr	13Cr
Total Assets	371.14Cr	427.78Cr	513.96Cr	566.42Cr	588.03Cr
Liabilities
Accounts Payable, Total	31Cr	32Cr	40Cr	47Cr	51Cr
Accrued Expenses, Total	1.9Cr	2.6Cr	3.06Cr	3.46Cr	2.59Cr
Short-term Borrowings	58Cr	43Cr	49Cr	47Cr	43Cr
Current Portion of Long-Term Debt	5.86Cr	11Cr	14Cr	21Cr	20Cr
Current Portion of Leases	1.01Cr	1.07Cr	77.49L	44.1L	65.94L
Current Income Taxes Payable	-	2.75Cr	7.5Cr	7.42Cr	5.85Cr
Other Current Liabilities	31Cr	17Cr	25Cr	27Cr	32Cr
Total Current Liabilities	128.31Cr	109.52Cr	139.13Cr	154.58Cr	156.12Cr
Long-Term Debt	21Cr	22Cr	27Cr	25Cr	17Cr
Long-Term Leases	2.01Cr	1.99Cr	1.75Cr	1.64Cr	1.73Cr
Deferred Tax Liability Non Current	94.83L	6.47Cr	6.94Cr	7.39Cr	8.83Cr
Other Non Current Liabilities	-	-	-	-	1.86Cr
Total Liabilities	152.63Cr	140.29Cr	174.51Cr	188.75Cr	185.43Cr
Common Stock, Total	9.19Cr	9.2Cr	9.2Cr	9.2Cr	9.2Cr
Additional Paid In Capital	35Cr	35Cr	36Cr	36Cr	36Cr
Retained Earnings	139.06Cr	208.18Cr	260.63Cr	299.27Cr	324.61Cr
Comprehensive Income and Other	35Cr	35Cr	34Cr	34Cr	33Cr
Total Common Equity	218.51Cr	287.49Cr	339.44Cr	377.67Cr	402.6Cr
Minority Interest	-6T	-7T	-9T	-12T	-14T
Total Equity	218.51Cr	287.49Cr	339.44Cr	377.67Cr	402.6Cr
Total Liabilities And Equity	371.14Cr	427.78Cr	513.96Cr	566.42Cr	588.03Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	9.19Cr	9.2Cr	9.2Cr	9.2Cr	9.2Cr
ECS Total Common Shares Outstanding	9.19Cr	9.2Cr	9.2Cr	9.2Cr	9.2Cr
Book Value / Share	23.78	31.25	36.88	41.03	43.74
Tangible Book Value	217.3Cr	286.5Cr	338.67Cr	377.11Cr	402.27Cr
Tangible Book Value Per Share	23.65	31.14	36.8	40.97	43.71
Total Debt	88Cr	80Cr	92Cr	96Cr	83Cr
Net Debt	69Cr	59Cr	80Cr	86Cr	76Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-2.03Cr	-1.31Cr	-52.52L	65.7L	1.53Cr
Debt Equivalent Oper. Leases	6.67Cr	7.84Cr	14Cr	17Cr	28Cr
Minority Interest, Total (Incl. Fin. Div)	-6T	-7T	-9T	-12T	-14T
Equity Method Investments, Total	45Cr	56Cr	70Cr	89Cr	94Cr
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	19Cr	24Cr	24Cr	25Cr	20Cr
Inventories - Work In Process, Total	13Cr	15Cr	12Cr	13Cr	13Cr
Inventories - Finished Goods, Total	26Cr	22Cr	32Cr	32Cr	50Cr
Inventories - Others	18.55L	8L	19.12L	8L	16.36L
Land - (BS)	34Cr	34Cr	34Cr	34Cr	34Cr
Buildings, Total	19Cr	20Cr	23Cr	24Cr	26Cr
Machinery, Total	85Cr	103.13Cr	128.18Cr	143.83Cr	155.32Cr
Full Time Employees	976	1.14T	996	1.51T	1.7T
Assets under Capital Lease - Gross	29Cr	31Cr	31Cr	32Cr	33Cr
Assets under Capital Lease - Accumulated Depreciation	-2.48Cr	-3.16Cr	-3.95Cr	-4.8Cr	-5.43Cr
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	36Cr	73Cr	57Cr	44Cr	30Cr
Depreciation & Amortization - CF	8.33Cr	9.26Cr	10Cr	12Cr	9.71Cr
Amortization of Goodwill and Intangible Assets - (CF)	21.84L	21.84L	21.84L	21.84L	21.84L
Depreciation & Amortization, Total	8.55Cr	9.48Cr	10Cr	12Cr	9.93Cr
(Gain) Loss From Sale Of Asset	-2L	-1.16Cr	-2L	-2L	-9L
(Gain) Loss on Sale of Investments - (CF)	-2L	-3L	-5L	-9L	3L
(Income) Loss On Equity Investments - (CF)	-9.47Cr	-11Cr	-14Cr	-19Cr	-5.93Cr
Stock-Based Compensation (CF)	-	-	-	-	-
Other Operating Activities, Total	14Cr	7.13Cr	2.69Cr	6.15Cr	6.04Cr
Change In Accounts Receivable	25Cr	-23Cr	-44Cr	-33Cr	84.31L
Change In Inventories	-3.89Cr	-2.32Cr	-8.14Cr	-1.62Cr	-14Cr
Change In Accounts Payable	1.11Cr	1.08Cr	8.17Cr	7.25Cr	4.15Cr
Change in Other Net Operating Assets	-14Cr	-18Cr	4.14Cr	6.38Cr	3.64Cr
Cash from Operations	57Cr	34Cr	16Cr	22Cr	35Cr
Capital Expenditure	-18Cr	-21Cr	-29Cr	-18Cr	-15Cr
Sale of Property, Plant, and Equipment	5L	1.32Cr	3L	2L	1.68Cr
Investment in Marketable and Equity Securities, Total	-	-	-	-	2L
Other Investing Activities, Total	2.34Cr	3.72Cr	4.75Cr	2.44Cr	1.55Cr
Cash from Investing	-16Cr	-16Cr	-24Cr	-16Cr	-12Cr
Short Term Debt Issued, Total	-	-	8.84Cr	5.51Cr	-
Long-Term Debt Issued, Total	7.26Cr	1.69Cr	4.56Cr	-	-
Total Debt Issued	7.26Cr	1.69Cr	13Cr	5.51Cr	-
Short Term Debt Repaid, Total	-20Cr	-8.29Cr	-	-	-4.64Cr
Long-Term Debt Repaid, Total	-66.07L	-84.31L	-76.35L	-2.09Cr	-8.16Cr
Total Debt Repaid	-20Cr	-9.13Cr	-76.35L	-2.09Cr	-13Cr
Issuance of Common Stock	2L	39.55L	8L	4L	-
Common Dividends Paid	-1.61Cr	-3.96Cr	-4.6Cr	-4.6Cr	-4.6Cr
Common & Preferred Stock Dividends Paid	-1.61Cr	-3.96Cr	-4.6Cr	-4.6Cr	-4.6Cr
Other Financing Activities, Total	-11Cr	-6.54Cr	-7.99Cr	-7.63Cr	-8.49Cr
Cash from Financing	-26Cr	-18Cr	13.62L	-8.77Cr	-26Cr
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	16Cr	1.26Cr	-7.73Cr	-2.62Cr	-3.36Cr
Supplemental Items
Cash Interest Paid	11Cr	6.54Cr	7.99Cr	7.63Cr	8.49Cr
Cash Income Tax Paid (Refund)	-8L	18Cr	16Cr	8.96Cr	11Cr
Levered Free Cash Flow	22Cr	1.41Cr	-25Cr	-7.3Cr	7.37Cr
Unlevered Free Cash Flow	29Cr	5.5Cr	-20Cr	-2.53Cr	13Cr
Change In Net Working Capital	-13Cr	37Cr	37Cr	21Cr	6.28Cr
Net Debt Issued / Repaid	-13Cr	-7.45Cr	13Cr	3.42Cr	-13Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	7.1	13.48	7.56	4.54	4.24
Return on Total Capital	8.61	15.99	8.91	5.42	5.1
Return On Equity %	17.78	28.81	18.15	12.14	7.65
Return on Common Equity	17.78	28.81	18.15	12.14	7.65
Margin Analysis
Gross Profit Margin %	65.26	61.76	65.88	63.62	66.88
SG&A Margin	19.23	15.46	22.04	26.14	28.25
EBITDA Margin %	21.19	24	18.82	13.37	12.1
EBITA Margin %	17.85	21.89	16.14	10.34	9.7
EBIT Margin %	17.75	21.83	16.07	10.28	9.65
Income From Continuing Operations Margin %	15.48	18.47	16.06	11.4	7.36
Net Income Margin %	15.48	18.47	16.06	11.4	7.36
Net Avail. For Common Margin %	15.48	18.47	16.06	11.4	7.36
Normalized Net Income Margin	11.2	15.09	12.79	8.75	6.11
Levered Free Cash Flow Margin	9.64	0.36	-6.96	-1.91	1.82
Unlevered Free Cash Flow Margin	12.62	1.39	-5.55	-0.66	3.13
Asset Turnover
Asset Turnover	0.64	0.99	0.75	0.71	0.7
Fixed Assets Turnover	1.8	2.82	2.29	2.28	2.35
Receivables Turnover (Average Receivables)	2.56	4.43	2.89	2.36	2.28
Inventory Turnover (Average Inventory)	1.42	2.53	1.86	1.99	1.73
Short Term Liquidity
Current Ratio	1.45	1.96	1.9	1.9	1.95
Quick Ratio	0.76	1.11	1.13	1.22	1.18
Operating Cash Flow to Current Liabilities	0.44	0.31	0.12	0.14	0.22
Days Sales Outstanding (Average Receivables)	142.49	82.4	126.49	154.82	159.79
Days Outstanding Inventory (Average Inventory)	257.58	144.31	195.89	183.86	210.5
Average Days Payable Outstanding	131.36	74.65	101.72	113.76	121.72
Cash Conversion Cycle (Average Days)	268.71	152.05	220.66	224.92	248.56
Long Term Solvency
Total Debt/Equity	40.19	27.74	27.22	25.37	20.62
Total Debt / Total Capital	28.67	21.71	21.39	20.23	17.09
LT Debt/Equity	10.7	8.45	8.38	7.09	4.62
Long-Term Debt / Total Capital	7.63	6.62	6.59	5.65	3.83
Total Liabilities / Total Assets	41.13	32.8	33.96	33.32	31.53
EBIT / Interest Expense	3.73	13.18	7.13	5.15	4.61
EBITDA / Interest Expense	4.51	14.63	8.44	6.75	5.78
(EBITDA - Capex) / Interest Expense	2.87	11.47	4.84	4.34	3.96
Total Debt / EBITDA	1.77	0.83	1.37	1.86	1.69
Net Debt / EBITDA	1.39	0.62	1.18	1.67	1.56
Total Debt / (EBITDA - Capex)	2.79	1.06	2.39	2.9	2.47
Net Debt / (EBITDA - Capex)	2.19	0.79	2.06	2.6	2.27
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	14.43	71.07	-10.21	7.74	6.22
Gross Profit, 1 Yr. Growth %	9.84	61.91	-4.23	4.05	11.67
EBITDA, 1 Yr. Growth %	38.32	93.75	-29.59	-23.45	-4.77
EBITA, 1 Yr. Growth %	49.13	109.82	-33.81	-30.95	-0.35
EBIT, 1 Yr. Growth %	49.52	110.41	-33.89	-31.07	-0.36
Earnings From Cont. Operations, 1 Yr. Growth %	44.07	104.13	-21.93	-23.51	-31.46
Net Income, 1 Yr. Growth %	44.07	104.13	-21.93	-23.51	-31.46
Normalized Net Income, 1 Yr. Growth %	53.79	130.49	-23.88	-26.3	-25.76
Diluted EPS Before Extra, 1 Yr. Growth %	44.01	103.58	-21.93	-23.5	-31.36
Accounts Receivable, 1 Yr. Growth %	-24.27	29.58	44.21	22.7	-0.47
Inventory, 1 Yr. Growth %	7.12	3.96	13.39	2.35	19.47
Net Property, Plant and Equip., 1 Yr. Growth %	9.75	8.34	12.68	3.89	2.42
Total Assets, 1 Yr. Growth %	6.07	15.26	20.14	10.21	3.82
Tangible Book Value, 1 Yr. Growth %	19.66	31.85	18.21	11.35	6.67
Common Equity, 1 Yr. Growth %	19.39	31.57	18.07	11.26	6.6
Cash From Operations, 1 Yr. Growth %	17.26T	-39.63	-53.21	37.29	57.1
Capital Expenditures, 1 Yr. Growth %	210.67	14.35	39.37	-35.93	-16.24
Levered Free Cash Flow, 1 Yr. Growth %	-188.61	-93.66	-1.85T	-70.39	-182.79
Unlevered Free Cash Flow, 1 Yr. Growth %	-260	-81.11	-457.83	-87.13	-406.66
Dividend Per Share, 1 Yr. Growth %	145.71	16.28	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	12.04	39.91	23.94	-1.64	6.98
Gross Profit, 2 Yr. CAGR %	14.75	33.36	24.53	-0.17	7.79
EBITDA, 2 Yr. CAGR %	363.12	63.7	16.8	-26.58	-14.24
EBITA, 2 Yr. CAGR %	173.76	76.89	17.85	-32.39	-17.05
EBIT, 2 Yr. CAGR %	167.76	77.37	17.94	-32.5	-17.12
Earnings From Cont. Operations, 2 Yr. CAGR %	82.16	71.49	26.24	-22.72	-27.59
Net Income, 2 Yr. CAGR %	82.31	71.49	26.24	-22.72	-27.59
Normalized Net Income, 2 Yr. CAGR %	81.34	88.27	32.46	-25.1	-26.03
Diluted EPS Before Extra, 2 Yr. CAGR %	82.2	71.22	26.07	-22.74	-27.53
Accounts Receivable, 2 Yr. CAGR %	3.17	-0.94	36.7	33.02	10.51
Inventory, 2 Yr. CAGR %	4.43	5.52	8.57	7.73	10.58
Net Property, Plant and Equip., 2 Yr. CAGR %	4	9.05	10.49	8.2	3.15
Total Assets, 2 Yr. CAGR %	8.7	10.57	17.68	15.07	6.96
Tangible Book Value, 2 Yr. CAGR %	17.85	25.6	24.84	14.73	8.99
Common Equity, 2 Yr. CAGR %	17.57	25.33	24.64	14.62	8.91
Cash From Operations, 2 Yr. CAGR %	128.38	923.7	-46.85	-19.85	46.86
Capital Expenditures, 2 Yr. CAGR %	78.92	88.48	26.24	-5.51	-26.75
Levered Free Cash Flow, 2 Yr. CAGR %	156.85	-76.3	5.26	127.72	-45.32
Unlevered Free Cash Flow, 2 Yr. CAGR %	204.83	-45.03	-17.82	-32.13	-19.69
Dividend Per Share, 2 Yr. CAGR %	-	69.03	7.83	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.26	29.02	20.68	18.29	0.91
Gross Profit, 3 Yr. CAGR %	3.26	28.7	19.43	17.29	3.63
EBITDA, 3 Yr. CAGR %	24.89	246.37	23.57	1.46	-19.7
EBITA, 3 Yr. CAGR %	32	150.53	27.47	-1.39	-23.06
EBIT, 3 Yr. CAGR %	32.31	147.09	27.65	-1.39	-23.14
Earnings From Cont. Operations, 3 Yr. CAGR %	47.05	89.21	31.93	6.83	-25.75
Net Income, 3 Yr. CAGR %	46.78	89.31	31.93	6.83	-25.75
Normalized Net Income, 3 Yr. CAGR %	53.48	96.43	39.22	8.94	-25.32
Diluted EPS Before Extra, 3 Yr. CAGR %	46.81	89.06	31.79	6.71	-25.72
Accounts Receivable, 3 Yr. CAGR %	4.19	11.32	12.27	31.86	20.76
Inventory, 3 Yr. CAGR %	5.67	4.27	8.08	6.46	11.51
Net Property, Plant and Equip., 3 Yr. CAGR %	2.03	5.43	10.24	8.24	6.24
Total Assets, 3 Yr. CAGR %	6.73	10.84	13.67	15.13	11.19
Tangible Book Value, 3 Yr. CAGR %	9.16	22.35	23.09	20.17	11.98
Common Equity, 3 Yr. CAGR %	8.96	22.06	22.86	20.01	11.88
Cash From Operations, 3 Yr. CAGR %	93.57	46.57	266.01	-27.08	0.31
Capital Expenditures, 3 Yr. CAGR %	23.38	54.12	70.44	0.7	-9.23
Levered Free Cash Flow, 3 Yr. CAGR %	11.13	-25.21	-0.61	-31.04	73.65
Unlevered Free Cash Flow, 3 Yr. CAGR %	44.26	20.62	2.62	-55.7	32.15
Dividend Per Share, 3 Yr. CAGR %	-	-	41.9	5.16	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.15	12.74	11.08	15.75	15
Gross Profit, 5 Yr. CAGR %	0.99	10.98	11.29	16.27	14.63
EBITDA, 5 Yr. CAGR %	5.08	23.37	21.59	86.23	6.78
EBITA, 5 Yr. CAGR %	9.4	27.26	26.15	48.36	7.34
EBIT, 5 Yr. CAGR %	9.28	27.41	26.36	47.04	7.39
Earnings From Cont. Operations, 5 Yr. CAGR %	17.01	35.49	38.34	32.25	3.78
Net Income, 5 Yr. CAGR %	17.01	35.49	38.19	32.29	3.78
Normalized Net Income, 5 Yr. CAGR %	17.84	40.24	44.7	33.58	8.1
Diluted EPS Before Extra, 5 Yr. CAGR %	15.42	35.02	38.13	32.18	3.74
Accounts Receivable, 5 Yr. CAGR %	10.28	15.82	16.14	19.54	11.56
Inventory, 5 Yr. CAGR %	0.08	4.65	6.82	5.64	9.08
Net Property, Plant and Equip., 5 Yr. CAGR %	2.15	2.2	5.33	6.53	7.35
Total Assets, 5 Yr. CAGR %	6.22	8.16	10.98	12.52	10.94
Tangible Book Value, 5 Yr. CAGR %	24.83	13.76	15.18	19.24	17.24
Common Equity, 5 Yr. CAGR %	24.17	13.53	14.98	19.03	17.08
Cash From Operations, 5 Yr. CAGR %	17.21	86.86	15.42	15.13	154.02
Capital Expenditures, 5 Yr. CAGR %	17.78	30.56	24.51	26.73	21.58
Levered Free Cash Flow, 5 Yr. CAGR %	8.47	-8.38	8.74	16.69	-21.74
Unlevered Free Cash Flow, 5 Yr. CAGR %	6.18	-8.98	15.18	-4.18	-6.97
Dividend Per Share, 5 Yr. CAGR %	-	-	-	-	23.36